Niagen Bioscience, Inc. — Director's Dealing 2010

Dec 10, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ChromaDex Corp. (CDXC.OB)
CIK: 0001386570
Period of Report: 2010-12-08

Reporting Person: Brauser Michael (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-12-08	Common Stock	P	2000	$1.56	Acquired	2149856	Direct
2010-12-09	Common Stock	P	3000	$1.49	Acquired	2152856	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1503570	Indirect

Footnotes

F1: See Footnote 2.

F2: Ownership: Michael & Betsy Brauser TBE own 1,795,714 shares of common stock; Betsy Brauser Third Amended Trust Agreement owns 357,142 shares of common stock. All shares owned by Betsy Brauser Third Amended Trust Agreement are beneficially owned by the Reporting Person's spouse and disclaimed by the Reporting Person.

F3: Ownership: Grander Holdings, Inc. 401K Profit Sharing Plan, of which the Reporting Person is the trustee, owns 314,285 shares of common stock; Brauser 2010 GRAT, of which the Reporting Person is the trustee, owns 342,857 shares of common stock; and BMB Holdings, LLLP, of which the Reporting Person is the manager of its general partner, owns 846,428 shares of common stock.